The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPUR.L Regulatory News (PUR)

  • There is currently no data for PUR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Statement re Possible Offer

22 Dec 2008 07:01

RNS Number : 5579K
Pure Wafer PLC
22 December 2008
 



FOR IMMEDIATE RELEASE

22 December 2008

Pure Wafer plc

Statement regarding possible offer

The board of Pure Wafer plc ("Pure Wafer" or "the Company") confirms that it has received a preliminary approach from a third party that may or may not lead to an offer being made for the CompanyThere is no certainty that a formal offer will be made for the Company or the terms on which any such offer might be made. A further announcement will be made in due course.

Dealing Disclosure Requirements 

Under the provisions of Rule 8.3 of the Takeover Code (the "Code"), if any person is, or becomes, "interested" (directly or indirectly) in 1% or more of any class of "relevant securities" of Pure Wafer, all "dealings" in any "relevant securities" of that company (including by means of an option in respect of, or a derivative referenced to, any such "relevant securities") must be publicly disclosed by no later than 3.30 pm (London time) on the London business day following the date of the relevant transaction. This requirement will continue until the date on which the offer becomes, or is declared, unconditional as to acceptances, lapses or is otherwise withdrawn or on which the "offer period" otherwise ends. If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to acquire an "interest" in "relevant securities" of Pure Wafer, they will be deemed to be a single person for the purpose of Rule 8.3.

Under the provisions of Rule 8.1 of the Code, all "dealings" in "relevant securities" of Pure Wafer by the offeror or the offeree company, or by any of their respective "associates", must be disclosed by no later than 12.00 noon (London time) on the London business day following the date of the relevant transaction.

A disclosure table, giving details of the companies in whose "relevant securities" "dealings" should be disclosed, and the number of such securities in issue, can be found on the Takeover Panel's website at www.thetakeoverpanel.org.uk.

"Interests in securities" arise, in summary, when a person has long economic exposure, whether conditional or absolute, to changes in the price of securities. In particular, a person will be treated as having an "interest" by virtue of the ownership or control of securities, or by virtue of any option in respect of, or derivative referenced to, securities.

Terms in quotation marks are defined in the Code, which can also be found on the Panel's website. If you are in any doubt as to whether or not you are required to disclose a "dealing" under Rule 8, you should consult the Panel.

In accordance with Rule 2.10 of the City Code on Takeovers and Mergers, Pure Wafer confirms that it currently has in issue 26,591,182 ordinary shares of 2p each. 

 

The International Securities Identification Number for the ordinary shares is GB00B02QYY79

ENDS

Enquiries:

Pure Wafer plc 01792 311 200

Peter Harrington, Chief Executive Officer

Altium  0161 831 9133

Phil Adams/Paul Lines

Financial Dynamics  020 7831 3113

Billy Clegg/Edward Westropp

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
OFDUARURWURUUUA
Date   Source Headline
15th Feb 20234:40 pmRNSSecond Price Monitoring Extn
15th Feb 20234:35 pmRNSPrice Monitoring Extension
7th Feb 20234:40 pmRNSSecond Price Monitoring Extn
7th Feb 20234:35 pmRNSPrice Monitoring Extension
7th Feb 20232:05 pmRNSSecond Price Monitoring Extn
7th Feb 20232:00 pmRNSPrice Monitoring Extension
31st Jan 20232:05 pmRNSSecond Price Monitoring Extn
31st Jan 20232:00 pmRNSPrice Monitoring Extension
27th Jan 20239:00 amRNSPrice Monitoring Extension
23rd Jan 20235:31 pmRNSCorrection - Notice of Intent to Delist from LSE
23rd Jan 20237:00 amRNSNotice of Intent to Delist from LSE
7th Dec 202211:05 amRNSSecond Price Monitoring Extn
7th Dec 202211:00 amRNSPrice Monitoring Extension
15th Nov 20228:01 amRNS3rd Quarter Results
11th Nov 20227:00 amRNSCourt Approval of Solicitation Process and Relief
2nd Nov 20227:00 amRNSTransfer of Listing from the TSX-V to the NEX
1st Nov 20222:05 pmRNSSecond Price Monitoring Extn
1st Nov 20222:00 pmRNSPrice Monitoring Extension
1st Nov 20227:00 amRNSPureGold Obtains CCAA Protection
31st Oct 20227:00 amRNSApplication for Initial Order for CCAA Protection
26th Oct 20229:05 amRNSSecond Price Monitoring Extn
26th Oct 20229:00 amRNSPrice Monitoring Extension
24th Oct 20224:40 pmRNSSecond Price Monitoring Extn
24th Oct 20224:35 pmRNSPrice Monitoring Extension
24th Oct 20229:05 amRNSSecond Price Monitoring Extn
24th Oct 20229:00 amRNSPrice Monitoring Extension
24th Oct 20227:00 amRNSPureGold Provides Financial and Operations Update
6th Oct 20224:27 pmRNSCorrection: Q3 Production and 4th Quarter Outlook
6th Oct 20227:03 amRNSQ3 Production Results and Fourth Quarter Outlook
26th Sep 20227:00 amRNSTechnical Report with Updated Mineral Resource
12th Sep 20227:00 amRNSRecord Gold Production; Reaffirms Q3 2022 Guidance
16th Aug 20227:00 amRNSOperations Update and Q2 2022 Financial Results
10th Aug 20227:00 amRNSUpdated Mineral Resource Estimate
12th Jul 20227:00 amRNSUS$6M Credit Facility & Strategic Review Process
20th Jun 20224:41 pmRNSSecond Price Monitoring Extn
20th Jun 20224:35 pmRNSPrice Monitoring Extension
15th Jun 20222:05 pmRNSGranting of Stock Options
6th Jun 202211:05 amRNSSecond Price Monitoring Extn
6th Jun 202211:00 amRNSPrice Monitoring Extension
6th Jun 20227:00 amRNSPDMR Unit Dealing
30th May 20227:00 amRNSFinal Tranche of Non-Brokered Private Placement
27th May 20222:56 pmRNSSecurities for Debt Transaction
27th May 20222:48 pmRNSFirst Tranche of Private Placement Closed
20th May 20227:01 amRNSAnticipated Closing Date of Private Placement
18th May 20222:22 pmRNSFirst Quarter Results
13th May 20227:00 amRNSExtension of Waiver Period by Sprott
9th May 20227:00 amRNSC$30 Million Non-Brokered Private Placement
22nd Apr 20224:41 pmRNSSecond Price Monitoring Extn
22nd Apr 20224:36 pmRNSPrice Monitoring Extension
22nd Apr 20222:05 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.